New York, NY, Dec. 12, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp., a Delaware corporation (the “Company”), reminds its stockholders that its 2024 Annual Meeting of Stockholders will be held 9:00 AM EST on December 23, 2024, at the Regus Conference Room at 35 Village Rd, Suite 100, Middleton, MA 01949, as per the Proxy Material mailed to shareholders on December 6, 2024.
Contacts:
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$1.58 |
| Daily Change: | -0.05 -3.07 |
| Daily Volume: | 17,942 |
| Market Cap: | US$2.940M |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
